IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $103,742 | -72.1% | 16,235 | -58.3% | 0.01% | -75.0% |
| Q3 2022 | $372,000 | +210.0% | 38,903 | +256.7% | 0.03% | +154.5% |
| Q2 2022 | $120,000 | +25.0% | 10,907 | +89.1% | 0.01% | +37.5% |
| Q1 2022 | $96,000 | +92.0% | 5,769 | +179.9% | 0.01% | +100.0% |
| Q3 2021 | $50,000 | +56.2% | 2,061 | +65.5% | 0.00% | +33.3% |
| Q2 2021 | $32,000 | +1500.0% | 1,245 | +2440.8% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 49 | -33.8% | 0.00% | – |
| Q2 2020 | $2,000 | -92.6% | 74 | -95.1% | 0.00% | -100.0% |
| Q3 2019 | $27,000 | -12.9% | 1,500 | +15.4% | 0.00% | 0.0% |
| Q2 2019 | $31,000 | -69.0% | 1,300 | -78.2% | 0.00% | -66.7% |
| Q1 2018 | $100,000 | – | 5,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |